Cas no 223644-10-8 (tert-butyl (3R)-3-methyl-1,4-diazepane-1-carboxylate)
tert-butyl (3R)-3-methyl-1,4-diazepane-1-carboxylate Chemical and Physical Properties
Names and Identifiers
-
- (R)-1-boc-3-methyl-[1,4]diazepane
- tert-butyl (3R)-3-methyl-1,4-diazepane-1-carboxylate
- (3R)-Hexahydro-3-methyl-1H-1,4-diazepine-1-carboxylic acid tert-butyl ester
- BS-16102
- F12731
- EN300-7126855
- MFCD15072097
- J-012568
- (R)-1-Boc-3-methyl-1,4-diazepane
- (R)-TERT-BUTYL3-METHYL-1,4-DIAZEPANE-1-CARBOXYLATE
- AC-30965
- AKOS027339909
- YIA64410
- DB-126368
- CS-0079658
- (R)-TERT-BUTYL 3-METHYL-1,4-DIAZEPANE-1-CARBOXYLATE
- 223644-10-8
- 867-393-6
-
- MDL: MFCD15072097
- Inchi: 1S/C11H22N2O2/c1-9-8-13(7-5-6-12-9)10(14)15-11(2,3)4/h9,12H,5-8H2,1-4H3/t9-/m1/s1
- InChI Key: GDTFCUXOVITPHU-SECBINFHSA-N
- SMILES: O(C(N1CCCN[C@H](C)C1)=O)C(C)(C)C
Computed Properties
- Exact Mass: 214.168127949g/mol
- Monoisotopic Mass: 214.168127949g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 15
- Rotatable Bond Count: 2
- Complexity: 223
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 1
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.2
- Topological Polar Surface Area: 41.6?2
Experimental Properties
- Density: 0.980
- Boiling Point: 288 oC
- Flash Point: 128 oC
tert-butyl (3R)-3-methyl-1,4-diazepane-1-carboxylate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM200521-1g |
(R)-1-Boc-3-methyl-[1,4]diazepane |
223644-10-8 | 97% | 1g |
$782 | 2021-06-09 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-BG229-200mg |
tert-butyl (3R)-3-methyl-1,4-diazepane-1-carboxylate |
223644-10-8 | 97% | 200mg |
1188.0CNY | 2021-07-17 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-BG229-50mg |
tert-butyl (3R)-3-methyl-1,4-diazepane-1-carboxylate |
223644-10-8 | 97% | 50mg |
475.0CNY | 2021-07-17 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-BG229-250mg |
tert-butyl (3R)-3-methyl-1,4-diazepane-1-carboxylate |
223644-10-8 | 97% | 250mg |
1593CNY | 2021-05-07 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-BG229-1g |
tert-butyl (3R)-3-methyl-1,4-diazepane-1-carboxylate |
223644-10-8 | 97% | 1g |
4099CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 65R0202-1g |
(R)-1-Boc-3-methyl-[1,4]diazepane |
223644-10-8 | 97% | 1g |
5071.29CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 65R0202-5g |
(R)-1-Boc-3-methyl-[1,4]diazepane |
223644-10-8 | 97% | 5g |
20268.21CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 65R0202-500mg |
(R)-1-Boc-3-methyl-[1,4]diazepane |
223644-10-8 | 97% | 500mg |
2959.67CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 65R0202-250mg |
(R)-1-Boc-3-methyl-[1,4]diazepane |
223644-10-8 | 97% | 250mg |
1908.1CNY | 2021-05-07 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 65R0202-100mg |
(R)-1-Boc-3-methyl-[1,4]diazepane |
223644-10-8 | 97% | 100mg |
1382.31CNY | 2021-05-07 |
tert-butyl (3R)-3-methyl-1,4-diazepane-1-carboxylate Related Literature
-
Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
-
Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
-
Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
-
Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
Additional information on tert-butyl (3R)-3-methyl-1,4-diazepane-1-carboxylate
tert-butyl (3R)-3-methyl-1,4-diazepane-1-carboxylate: A Comprehensive Overview
tert-butyl (3R)-3-methyl-1,4-diazepane-1-carboxylate, identified by the CAS registry number CAS No. 223644-10-8, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound belongs to the class of diazepanes, which are seven-membered rings containing two nitrogen atoms. The tert-butyl group attached to the carboxylic acid moiety suggests its potential as a prodrug or a bioisostere in drug design.
The structure of tert-butyl (3R)-3-methyl-1,4-diazepane-1-carboxylate features a chiral center at the third position of the diazepane ring, denoted by the (R) configuration. This stereochemistry is crucial for its biological activity, as it determines the compound's interaction with target receptors or enzymes. Recent studies have highlighted the importance of stereochemistry in drug efficacy and selectivity, making this compound a valuable model for exploring structure-activity relationships.
Research into CAS No. 223644-10-8 has focused on its potential applications in medicinal chemistry. For instance, investigations into its pharmacokinetic properties have revealed promising bioavailability profiles, suggesting its suitability for oral administration. Additionally, studies on its metabolic pathways have provided insights into its stability and clearance mechanisms within the body.
The synthesis of tert-butyl (3R)-3-methyl-1,4-diazepane-1-carboxylate involves multi-step organic reactions, including ring-closing metathesis and stereoselective alkylation. These methods have been optimized to ensure high yields and enantioselectivity, which are critical for large-scale production in pharmaceutical settings.
In terms of biological activity, recent findings indicate that this compound exhibits moderate inhibitory effects on certain enzymes implicated in neurodegenerative diseases. This has led to exploratory studies on its potential as a therapeutic agent for conditions such as Alzheimer's disease or Parkinson's disease. However, further research is required to establish its efficacy and safety profile in preclinical models.
The development of analogs based on CAS No. 223644-10-8 has also been an area of active investigation. By modifying substituents on the diazepane ring or altering the tert-butyl group, researchers aim to enhance pharmacokinetic properties or improve target specificity. These efforts underscore the versatility of this compound as a scaffold for drug discovery.
In conclusion, tert-butyl (3R)-3-methyl-1,4-diazepane-1-carboxylate, with its unique chemical structure and promising biological properties, represents an important molecule in contemporary medicinal chemistry research. As ongoing studies continue to elucidate its mechanisms of action and therapeutic potential, this compound holds promise for advancing novel treatments in various disease areas.
223644-10-8 (tert-butyl (3R)-3-methyl-1,4-diazepane-1-carboxylate) Related Products
- 549479-81-4(2-(aminomethyl)-4-methyl-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester)
- 194032-35-4(Tert-Butyl 3-Methyl-1,4-Diazepane-1-Carboxylate)
- 868407-41-4(tert-butyl 3,7,9-triazabicyclo[3.3.1]nonane-3-carboxylate)
- 194032-32-1(tert-butyl (3S)-3-methyl-1,4-diazepane-1-carboxylate)
- 1260422-99-8(tert-Butyl 2-methyl-1,4-diazepane-1-carboxylate)
- 1064048-78-7(N-methyl-N-(2-piperazinylmethyl)-Carbamic acid 1,1-dimethylethyl ester)
- 1035226-84-6(tert-butyl (2S)-2-methyl-1,4-diazepane-1-carboxylate)
- 1376099-80-7(tert-Butyl 3-(aminomethyl)piperazine-1-carboxylate)
- 864448-35-1(Tert-butyl 7-methyl-3,7,9-triaza-bicyclo[3.3.1]nonane-3-carboxylate)
- 1159825-34-9(tert-butyl 1,3,4,6,7,8,9,9a-octahydropyrazino[1,2-a]pyrazine-2-carboxylate)